The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

immunemed.co.kr

Total Raised

$36.65M

Deal Terms

2

ImmuneMed Funding, ImmuneMed Valuation & ImmuneMed Revenue

6 Fundings

ImmuneMed's latest funding round was a Series D for $10.16M on November 3, 2021.

ImmuneMed's valuation in July 2018 was $88.08M.

ImmuneMed's latest post-money valuation is from July 2018.

Sign up for a free trial to see ImmuneMed's valuations in October 2017 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/3/2021

Series D

$10.16M

0

FY undefined

1

4/5/2019

Series C

$99M

0

FY undefined

10

7/23/2018

Series B - II

$99M

$88.08M

0

FY undefined

10

10/19/2017

Series B

$99M

$99M

0

FY undefined

10

4/14/2016

Series A - II

$99M

0

FY undefined

10

Date

11/3/2021

4/5/2019

7/23/2018

10/19/2017

4/14/2016

Round

Series D

Series C

Series B - II

Series B

Series A - II

Amount

$10.16M

$99M

$99M

$99M

$99M

Investors

Valuation

$88.08M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

ImmuneMed Deal Terms

2 Deal Terms

ImmuneMed's deal structure is available for 2 funding rounds, including their Series B - II from July 23, 2018.

Round

Series B - II

Series B

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B - II

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

$99M

$99M

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.